Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations,® aims to promote awareness of the major democratic principles on which tolerance is based.

COVID vaccine weekly: support builds for patent waiver as shortages threaten to bite

By Rob Reddick, Commissioning Editor, COVID-19
Share this article
The US has this week backed a proposal to allow countries to manufacture COVID-19 vaccine doses without needing the agreement of the vaccines’ rights holders. This would be enabled by temporarily waiving intellectual property (IP) protection on all COVID-19 medical products. Removing such protections, the waiver’s proponents argue, will increase the amount of vaccine doses produced globally.

This is the theory. But in practice, waiving IP is unlikely to be a short-term solution to increasing vaccine manufacture, argues

Read complete article

© The Conversation -

Follow us on ...
Facebook Twitter